Yesterday in the evening, the Verkhovna Rada of Ukraine adopted draft law No. 6776-Д dated November 14th, 2017 on amendments to the Tax Code of Ukraine regarding the balance of budget revenues in 2018 (http://w1.c1.rada.gov.ua/pls / zweb2 / webproc4_1? pf3511 = 62878).
The draft law, in particular, provides for amendments to part 2 of subparagraph "c" of paragraph 193.1 of Article 193 of the Tax Code of Ukraine.
According to the new edition of the relevant norm, VAT rate of 7% will apply to supplies of goods in the customs territory of Ukraine and the importation into the customs territory of Ukraine of all medical products not included in the state register of medical equipment and medical devices, or those that meet the requirements of the relevant technical regulations, which is confirmed by the compliance document, and are allowed for placing on the market and / or putting into operation and use in Ukraine.
It should be noted that today 7% VAT rate applies exclusively to the operations of supplying in the customs territory of Ukraine and the importation into the customs territory of Ukraine of medical products based on the list approved by the Cabinet of Ministers of Ukraine (http://zakon2.rada.gov.ua). / laws / show / 410-2014-% D0% BF / paran10 # n10). 20% VAT is levied on supply in the customs territory of Ukraine and the import into the customs territory of Ukraine of medical products not included in this list.
In addition, 7% VAT rate remains for supply operations in the customs territory of Ukraine and the import into the customs territory of Ukraine of medicines, medical products and / or medical equipment authorized for use for clinical trials, the permission for which is provided by the respective ministry.
We are thrilled to announce a major milestone in our team's growth and celebrate the well-deserved career advancements of our colleagues.
Lexology Index: Employment & Labor highlights the leading legal specialists in the field from around the world.
On June 19, 2026, an event was held with the participation of businesses, regulators, and experts – titled “Regulatory Dialogue: The Cosmetics Market” – organiz
The event brought together leading industry experts for a comprehensive analysis of the institutional landscape and current legal challenges in the sphere of state-business interaction.